-
Founded in:
1996-03-25 -
Country:
China -
Address:
No. 98, Hehai Road, Xinbei District, Changzhou -
Tax NO.:
91320411608126453T -
Registered Funds:
$18 million -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Trazodone hydrochloride |
Extract from the above information
More
Extract from the above information |
25332-39-2 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Trazodone hydrochloride |
It is a specific 5-hydroxytryptamine reuptake inhibitor. Due to its alpha 1 adrenergic antagonism and antihistamine effects, it can induce postural hypotension. It is not a monoamine oxidase inhibitor, and unlike amphetamines, it has no excitatory effect on the central nervous system.
More
It is a specific 5-hydroxytryptamine reuptake inhibitor. Due to its alpha 1 adrenergic antagonism and antihistamine effects, it can induce postural hypotension. It is not a monoamine oxidase inhibitor, and unlike amphetamines, it has no excitatory effect on the central nervous system. |
25332-39-2 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zaleplon |
Extract from the above information
More
Extract from the above information |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zaleplon |
Extract from the above information
More
Extract from the above information |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium risedronate |
It can bind to hydroxyapatite in bones and inhibit bone resorption. At the cellular level, this product inhibits osteoclasts. It reduces the absorption of bone turnover and bone remodeling, inhibits osteoclasts in osteoporosis model rats and miniature pigs, increases bone mass and bone biomechanical strength, and the increase in bone density is dose-related.
More
It can bind to hydroxyapatite in bones and inhibit bone resorption. At the cellular level, this product inhibits osteoclasts. It reduces the absorption of bone turnover and bone remodeling, inhibits osteoclasts in osteoporosis model rats and miniature pigs, increases bone mass and bone biomechanical strength, and the increase in bone density is dose-related. |
115436-72-1 | 13 |